Home › Refractory Anemia na May Sobrang Blasts
Pag-aaral pangklinika para sa Refractory Anemia na May Sobrang Blasts na nagre-recruit sa U.S.
19 pag-aaral para sa Refractory Anemia na May Sobrang Blasts ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX6 pag-aaral
- Seattle, WA5 pag-aaral
- New York City, NY3 pag-aaral
- Boston, MA3 pag-aaral
- Washington, DC3 pag-aaral
- Columbus, OH3 pag-aaral
Ayos sa estado
- Maryland3 pag-aaral
- Massachusetts3 pag-aaral
- New York3 pag-aaral
- North Carolina3 pag-aaral
- Ohio4 pag-aaral
- Texas7 pag-aaral
- Washington5 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
Nagre-recruitPhase 2
Edad 6 hanggang 70 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT01861106Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
Nagre-recruitPhase 1/2
Edad 12 hanggang 120 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06303193Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
Nagre-recruitPhase 2
Edad 4 hanggang 80 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT01174108Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT00801489Luspatercept + Darbepoetin in MDS
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07096297Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
Nagre-recruitPhase 2
Edad 12 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT03383575Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07249346Personalized NK Cell Therapy in CBT
Nagre-recruitPhase 2
Edad 15 hanggang 80 · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT02727803Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Nagre-recruitPhase 2
Hanggang edad 60 · Lahat ng kasarian · Na-update Hun 25, 2026 · NCT03314974211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
Nagre-recruitPhase 1/2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hun 22, 2026 · NCT03670966211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
Nagre-recruitPhase 1/2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hun 22, 2026 · NCT03128034MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
Nagre-recruit
Edad 0 hanggang 25 · Lahat ng kasarian · Na-update May 13, 2026 · NCT05794880A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 30, 2026 · NCT04256317Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Nagre-recruitPhase 1/2
1 Month – 25 Years · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT06839456MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Nagre-recruitPhase 2
Hanggang edad 60 · Lahat ng kasarian · Na-update Abr 6, 2026 · NCT05735717A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Nagre-recruitPhase 2
Edad 18 hanggang 66 · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06859424Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
Nagre-recruitPhase 2
Hanggang edad 21 · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT04644016Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 10, 2025 · NCT06680752HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
Nagre-recruitPhase 2
3 Months · Lahat ng kasarian · Na-update Nob 12, 2025 · NCT02143830Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.